RxDoctor Payments Data

Peter Crosby, MD

Family Medicine · Norwalk, OHNPI 1356337398

Payments from drug & device makers

$3,490in general payments, 2019–2025

Across 213 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$240
  • Lilly USA, LLC$240
  • Pfizer$222
  • AstraZeneca$213
  • Abbott$182
  • plus $794 from 17 others

What the payments were for

  • Food & beverage$3,490100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,490 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$142,958
Medicare patients
330
Services billed
2,365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$142,101
OzempicSemaglutide135$134,318
MounjaroTirzepatide65$75,735
JanuviaSitagliptin Phosphate56$69,457
XareltoRivaroxaban41$43,016
JardianceEmpagliflozin61$41,008
TrulicityDulaglutide37$35,331
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$33,335
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$14,590
Lantus SolostarInsulin Glargine,hum.Rec.Anlog58$10,952
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate17$7,464
Potassium Chloride213$5,596
Albuterol Sulfate HfaAlbuterol Sulfate237$5,406
Breo ElliptaFluticasone/Vilanterol11$4,191
Pantoprazole Sodium253$3,625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$222$142,101117 claims
Novo NordiskOzempic$240$134,318135 claims
Lilly USA, LLCMounjaro, Trulicity$240$111,066102 claims
Johnson & JohnsonXarelto$29$43,01641 claims
GSKTrelegy Ellipta, Breo Ellipta$118$37,52642 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Norwalk

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →